Burden of Care of Long COVID Patients After Hospital Discharge

Summary

Since March 2020, 3.5 million people have been infected with SARS-COV2 in France, and about 250 000 patients have been hospitalized and successfully discharged.

In a majority of cases, the evolution of the disease is favourable, but both hospitalized or patients with a mild form of the disease may present so called "Long-COVID" syndrome - a patient-created term which describes the effects of COVID-19 that continue for weeks or months beyond the initial symptoms. There is thus an urgent need to evaluate the long-term medical resource utilisation (MRU) and health care burden incurred by patients with Long-COVID, as well as risk factors for Long-COVID.

We will use the SNDS database to extract and analyze the data relevant to the project objectives. Indeed, the SNDS database is the French NHS database providing individual anonymous information of primary and secondary care linked at individual level (data from PMSI, the French DRG-based medical information system). It currently covers more than 98% of the French population.

For the first time, our study will provide an estimation of MRU and associated costs of hospitalized COVID-19 patients. It will also provide an estimation of the rate of long COVID forms developed by hospitalized COVID patients, as well as detailed MRU and costs incurred by long COVID patients compared to patients with non-long COVID-19.

Conditions

• COVID-19
• COVID Long

Interventions

OTHER

COVID-19 required hospitalisation

Patients who contracted a COVID19 required hospitalisation

Sponsors & Collaborators

• PELyon

  collaborator UNKNOWN

• Mikhail Dziadzko, MD, PhD

  lead OTHER

Principal Investigators

• Mikhail DZIADZKO, MD, PhD · Hospices Civils de Lyon

• Frederic Aubrun, MD, PhD · Hospices Civils de Lyon

• Eric VAN-GANSE, MD, PhD · Hospices Civils de Lyon

• Pierre ALBALADEJO, MD, PhD · CHU Grenoble Alpes

• Florence ADER, MD, PhD · Hospices Civils de Lyon

• Valeria MARTINEZ, MD, PhD · Hôpital Raymond-Poincaré - APHP

• Claire MARANT-MICALLEF, PharmD, MPH · PELyon

• Manon BELHASSEN, MD, PhD · PELyon

• Fabrice HERITIER, MD · Hospices Civils de Lyon

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-01-01

Primary Completion

2022-07-12

Completion

2022-08-10

Countries

• France

Study Locations